Browse life science companies in Cambridge, home to one of Europe's leading biotechnology and life science ecosystems.
Rapid diagnostic platforms for infectious disease and consumer testing
Sapphiros is a privately held diagnostics portfolio company backed by KKR and Neoenta. UK operations include Biocrucible, a molecular diagnostics company developing ultra-rapid isothermal nucleic acid amplification assays, and an Extreme Volume Manufacturing capability producing lateral flow diagnostic tests at…
Life sciences membership organisation and industry network
One Nucleus is a not-for-profit life sciences and healthcare membership organisation headquartered in Cambridge, serving over 400 member companies across the Cambridge/London corridor and beyond. It provides networking events, training, business development support and access to international partnering conferences,…
Tunable covalent chemistry platform for neurodegenerative disease
Dunad Therapeutics is a drug discovery biotech developing small molecule therapies for neurodegenerative diseases including ALS, frontotemporal dementia, and Parkinson's disease. Its platform combines tunable covalent chemistry with targeted protein degradation, using monovalent small molecules that form durable bonds…
Recombinant proteins and custom protein production for researchers
Cambridge Protein Works supplies purified recombinant proteins and custom production services to academic and industrial researchers. Its catalogue includes specialist protein reagents, while bespoke services accommodate specific protein variants and experimental requirements. The company also prepares samples for…
Antibody therapy to deplete amyloid deposits in ATTR cardiomyopathy
Immutrin is a biotechnology company developing an engineered antibody therapeutic designed to actively remove amyloid deposits from tissues in patients with amyloidosis. Its lead asset targets ATTR cardiomyopathy, a progressive and often fatal cardiac disease caused by transthyretin amyloid accumulation, for which no…
In vivo cell reprogramming therapies for degenerative disease
Mogrify is a biotechnology company developing a novel class of in vivo reprogramming therapies for degenerative diseases. Its proprietary platforms use large-scale transcriptomic and epigenomic network data to predict the transcription factors required to convert mature human cells directly into target therapeutic…
Cell rejuvenation to reverse disease and age-related disability
Altos Labs studies cellular rejuvenation, aiming to restore cell resilience and understand biological processes underlying disease, injury and ageing. Its international research institutes combine experimental biology, computational science and therapeutic development. Research includes cellular reprogramming and…
Next-generation targeted protein degradation therapeutics
Amphista Therapeutics is a Cambridge-based biopharmaceutical company developing next-generation targeted protein degradation medicines. Its proprietary platform generates bifunctional small molecule degraders that harness a broader range of the cell's protein-degrading machinery than existing approaches, enabling…
Plant-based molecular farming platform for bio-identical collagen production
LeafyColl is a biotech developing a molecular farming platform for the scalable, plant-based production of bio-identical human collagen and other specialty proteins. The system uses engineered plants as programmable bio-factories to produce high-purity collagen for applications spanning regenerative medicine, wound…
Programmable RNA for scalable cell engineering and biomanufacturing
Plurify is a biotechnology company developing PluRNA, a programmable RNA platform for sustained protein expression without genome integration. Its technology is designed to engineer cells through controllable RNA-based programmes, with applications in stem-cell therapy manufacturing, cell purification, biologics…
Instrument-free single-cell RNA sequencing kits for scalable genomic analysis
CS Genetics is a genomics tools company developing instrument-free reagent kits for single-cell transcriptomics. Its platform uses a proprietary process in which bifunctional bead reagents pair with individual cells through stoichiometric geometry, enabling single-cell RNA sequencing in standard laboratory plasticware…
LNP-mRNA growth factor therapy to restore hearing loss
CamGene Therapeutics is a preclinical biotechnology company developing lipid nanoparticle-delivered mRNA medicines to treat hearing loss at its underlying cellular cause. Its lead approach uses an LNP-mRNA growth factor therapeutic designed to regenerate cochlear nerve cells and reduce inflammation, aiming to restore…
Contract microscopy imaging and analysis services for life sciences
Nikon BioImaging Lab is a contract research organisation based at the Babraham Research Campus in Cambridge, providing microscope-based imaging and analysis services to biotech and pharmaceutical clients. Services span sample imaging, high-content acquisition, AI-powered data analysis using Nikon's NIS Elements…
Gene therapy immune regulators for infection, cancer and autoimmunity
Virothera develops gene therapies intended to regulate immune responses in persistent diseases. Its approach draws on human versions of immune-modifying proteins that viruses have evolved to influence immune cells. The company aims to use these proteins to create targeted treatments with potential advantages over some…
Molecular disease research spanning genetics, neurobiology and intracellular infections
Cambridge Institute for Medical Research is a University of Cambridge institute studying the molecular mechanisms of human disease. Researchers investigate protein folding, cellular quality control, membrane trafficking and organelle function, focusing on rare genetic disorders, neurological conditions and…
Single-cell sequencing kits, instruments and genomic analysis services
Singleron Biotechnologies is a life science tools company providing single-cell sequencing technologies and genomic analysis services. Its portfolio includes microfluidic sample-processing kits, instruments, library preparation reagents and bioinformatics software for studying gene expression and molecular features in…
Collagen-based biomaterials as sustainable alternatives to leather
PACT Earth is a UK biotechnology company developing collagen-based biomaterials for the fashion and textiles industries. Its flagship material is produced from ethically sourced collagen derived from freshwater fish farming by-products, processed without synthetic plastics or harsh chemicals. PACT targets brand…
Single-cell genomics and AI platform for autoimmune and fibrotic disease
Ensocell is a Cambridge-based biotechnology company developing precision biologics for autoimmune, inflammatory, and fibrotic diseases. Its platform integrates single-cell and spatial genomics with AI-based computational tools and advanced cell models to identify novel disease intervention points and design targeted…
RNA immunotherapies targeting novel tumour-specific antigens
Epitopea is a biopharma company developing off-the-shelf RNA-based immunotherapies for hard-to-treat cancers. Using spatial immunopeptidomics, genomics, and systems bioinformatics, the company identifies aberrantly-expressed tumour-specific antigens that are broadly shared across patients with the same tumour type.…
Agricultural technology membership network
Agri-TechE is an independent, not-for-profit membership organisation, headquartered in Cambridge and operating without government funding. It connects farmers, researchers, technologists, entrepreneurs and agribusinesses through events, site visits, funding support and collaborative projects, with its flagship annual…